LAMIAPHARM
ActiveSummary
LAMIAPHARM has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €47,878 and a net result of €44,992. Its solvency ranks better than 68% of 9,617 sector peers (NACE 82, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
History
On 27 December 2024, LAMIAPHARM was incorporated as a private limited company by one natural person, with a starting capital of €3,000.12 TISSAFI IDRISSI HALI Lamiaa has served as director of the company since 2024.2 The company has filed 2 sets of annual accounts, the latest for financial year 2025.3
Acts, filings and financial milestones
31-12
Gazette deed
IncorporationAppointment: TISSAFI IDRISSI HALI Lamiaa (director) · Permanent representative: TISSAFI IDRISSI HALI Lamiaa · Founder10 facts ▸
- Incorporation, 26-12-2024
- Founder, TISSAFI IDRISSI HALI Lamiaa (comparant,fondateur)
- Founding capital, €3,000
- Capital
- General meeting, “décisions finales et transitoires, comparant formant assemblée” (deed in French)
- Registered office clause, “5100 Namur (Wierde),Avenue du Bois l'Evêque,11” (deed in French)
- Board rule, 1
- Director appointment, TISSAFI IDRISSI HALI Lamiaa (director (not named in the articles))
- Permanent representative, TISSAFI IDRISSI HALI Lamiaa (représentant permanent de la société)
- Pre-incorporation commitments, “takeover, engagements,obligations et activités au nom et pour compte de la société en formation” (deed in French)